HealthQuill Medical
Sudanā€™s humanitarian crisis and security situation remain ā€œdire and worsening,ā€ with a famine looming on the horizon, according to a UN official.
Drugs Health Medical

Sudan heading for famine as fighting ravages Darfur, UN warns

HQ Team April 2, 2025: Sudanā€™s humanitarian crisis and security situation remain ā€œdire and worsening,ā€ with a famine looming on the horizon, according.

Read More
Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from Biogen Inc., for an undisclosed amount.
Drugs Medical Pharma

Organon & Co. buys biosimilar from Biogen for an undisclosed sum

HQ Team April 2, 2025: Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from.

Read More
The US Food and Drug Administration has approved Britainā€™s GSK Plcā€™s drug to treat urinary tract infections in adult women and girls above 12 years, according to the company.
Drugs Medical Pharma

GSKā€™s drug to fight urinary tract infections gets USFDA approval

HQ Team March 26, 2025: The US Food and Drug Administration has approved Britainā€™s GSK Plcā€™s drug to treat urinary tract infections in.

Read More
The Cystic Fibrosis Foundation will invest up to $2.3 million in Owlstone Medical to develop a test that is designed to detect Pseudomonas infections from a personā€™s breath.
Drugs Health Medical

CF Foundation to fund project to find lung infections from people’s breath

HQ Team March 26, 2025: The Cystic Fibrosis Foundation will invest up to $2.3 million in Owlstone Medical to develop a test that.

Read More
The World Health Organization has issued new guidelines to help reform and strengthen mental health policies and systems at a time when up to 90% of the people in some nations with severe mental health conditions receive no care at all.
Health Medical Pharma

WHO unveils new guidelines to tackle mental health systems, policies

HQ Team March 26, 2025: The World Health Organization has issued new guidelines to help reform and strengthen mental health policies and systems.

Read More
Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and commercialising of the Chinese companyā€™s ā€œtriple Gā€ weight-loss candidate.
Drugs Medical Pharma

Novo Nordisk in $2b deal with Chinese firm for ā€˜triple-Gā€™ obesity drug

HQ Team February 25, 2025: Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and.

Read More
Obesity is a health risk that needs to be tackled worldwide
Health Medical

Weight loss offers health benefits, even if pounds creep back: Study

Bharti Jayshankar March 24, 2025: University of Gothenburg researchers have uncovered a silver lining for those who struggle to maintain weight loss. According.

Read More
Novo Nordisk will pay Gensaic, Inc., a biotechnology company, an upfront payment of $354 million for the latterā€™s technology to discover tissue-targeting molecules.
Drugs Medical Pharma

Novo Nordisk to pay US-based Gensaic $354 million upfront in licensing deal

HQ Team March 5, 2025: Novo Nordisk will pay Gensaic, Inc., a biotechnology company, an upfront payment of $354 million for the latterā€™s.

Read More
AbbVie Inc. will license a drug to treat obesity from Denmarkā€™s Gurba A/S, a preclinical contract research services and peptide-based drug discovery, for about $2.2 billion to mark its entry into the obesity treatment space.
Drugs Medical Pharma

AbbVie inks $2.2b deal with Denmarkā€™s Gurba, enters weight-loss market

Ā HQ Team March 4, 2025: AbbVie Inc. will license a drug to treat obesity from Denmarkā€™s Gurba A/S, a preclinical contract research services.

Read More
Thermo Fisher Scientific to buy Solvemtumā€™s purification unit for $4.1 billion in cash
Drugs Medical Pharma

Thermo Fisher to buy Solventumā€™s filtration unit for $4.1 billion in cash

HQ Team March 1, 2025: Thermo Fisher Scientific Inc., will buy Solventumā€™s purification and filtration business for $4.1 billion in cash to support.

Read More